BeOne Medicines
ONC
#622
Rank
$42.22 B
Marketcap
$373.27
Share price
-0.67%
Change (1 day)
20.83%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

ESG Reports

Thumbnail BeOne Medicines ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2021

ESG Report 2021

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2020

ESG Report 2020

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2019

ESG Report 2019

Language: English

View ESG Report